Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Leukemia
Leukemia
Psychological Distress and Financial Burden Impact Adherence to CML Treatment
Phoebe Starr
Play Video
Leukemia
Refining the Use of CAR T-Cells in Patients with Acute Lymphoblastic Leukemia
Phoebe Starr
Play Video
Leukemia
Researchers Identify First Mutation to Explain Resistance to Venetoclax
Phoebe Starr
Phoebe Starr
Play Video
FDA Approvals
,
Leukemia
,
Lymphoma
,
Conference Highlights ASCO
Rylaze FDA Approved as Part of a Treatment Regimen for Pediatric Leukemia and Lymphoma
Play Video
Leukemia
Sorafenib Prolongs Event- and Relapse-Free Survival in Acute Myeloid Leukemia
Play Video
Leukemia
Strategies to Reduce the Use of Tyrosine Kinase Inhibitors in CML
Phoebe Starr
Play Video
Leukemia
Umbralisib plus Ublituximab Combination Superior to Chemoimmunotherapy in Patients with Chronic Lymphocytic Leukemia
Wayne Kuznar
Wayne Kuznar
Play Video
Leukemia
Venetoclax plus Intensive Chemotherapy Shows Promising Results in All Patients with Acute Myeloid Leukemia
Chase Doyle
Chase Doyle
Play Video
Leukemia
Zanubrutinib, Next-Generation BTK, Leads to Impressive Responses in Patients with CLL or SLL
Phoebe Starr
Phoebe Starr
Play Video
Leukemia
“Dramatic” Responses with Targeted Agent for Patients with CLL
Charles Bankhead
Play Video
4
5
6
7
Page 7 of 7
Results 61 - 70 of 70